2017 Apr 28
Hitting Her Stride
Profile of Lisa Roth, M.D., as an oncologist, cancer survivor and distance runner Read more
2017 Apr 28
WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine
A $5 million gift will establish a new initiative to use predictive tools to enhance Weill Cornell Medicine’s precision medicine efforts. Read more
2017 Apr 28
Immune cells play crucial role in brain cancer development
Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to studies led by Jeffrey Greenfield, M.D., Ph.D. Read more
2017 Apr 26
Five Weill Cornell medical students win prestigious Howard Hughes Fellowships
Several cancer projects will get a boost thanks to prestigious research fellowships from the Howard Hughes Medical Institute. Read more
2017 Apr 21
This professor will march to remind the world why government should support scientific exploration
Harold Varmus, M.D., explains "the profound need to reassert public support for rational thought." Read more
2017 Apr 20
We Are Weill Cornell Medicine: Dr. Adrienne Phillips
Profile of Adrienne Phillips, M.D., as part of the #WeAreWCM campaign. Read more
2017 Apr 18
Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy
John Leonard, M.D., discusses the optimal follicular lymphoma treatment. Read more
2017 Apr 17
New study challenges diagnostic approach for common urological condition
Combining kidney ultrasound with a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract in people with microscopic amounts of blood in their urine, according to Weill Cornell urologists Read more
2017 Apr 14
Expanded drug combinations produce best myeloma induction
Ruben Niesvizky, M.D., discusses the optimal induction therapy for patients with multiple myeloma. Read more
2017 Apr 11
The federal panel that opposed prostate cancer screening just changed its mind
Jim Hu, M.D., comments on new PSA screening guidelines issued by the U.S. Preventive Services Task Force Read more
2017 Apr 07
Giving terminally ill patients the 'Right-to-Try'
Manish Shah, M.D., weighs in on proposed 'right-to-try" legislation that would give terminally ill patients access to experimental drugs. Read more
2017 Apr 06
We Are Weill Cornell Medicine: Dr. Praveen Raju
Praveen Raju, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Apr 05
In 2030, the top cancer in HIV patients may be a surprise
Ethel Cesarman, M.D., Ph.D., comments on a study about cancers linked to AIDS and suppressed immunity. Read more
2017 Apr 05
Indications of Early-Onset CRC
Manish A. Shah, M.D., discusses his research into indications of early-onset colorectal cancer. Read more
2017 Apr 05
Evolving therapeutic strategies in renal cell carcinoma
David Nanus, M.D., discusses evolving therapeutic strategies in the neoadjuvant and adjuvant setting for patients with RCC at the 2017 Interdisciplinary Prostate Cancer Congress. Read more
2017 Apr 05
Long-term aspirin may cut risk for cancer death
Manish Shah, M.D., comments on a study about the association of long-term aspirin use and cancer death. Read more
2017 Apr 03
Investigators Named to Stand Up 2 Cancer’s Colorectal Dream Team
Weill Cornell Medicine and NewYork-Presbyterian have been named to the nonprofit Stand Up 2 Cancer’s Colorectal Dream Team to drive new advances in colorectal cancer research and treatment. The interdisciplinary team, funded... Read more
2017 Apr 03
Weill Cornell Medicine joins colorectal cancer 'Dream Team'
A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers. Read more
2017 Apr 02
Bringing bladder cancer into focus
Bishoy Faltas, M.D., and LaMont Barlow, M.D., are exploring FAK inhibition as a potential targeted therapy for urothelial cancer. Read more
2017 Apr 02
Cell therapy provides shot at a cure for fatal thyroid cancer
In the first demonstration of the potential for CAR-T therapy for previously untreatable advanced thyroid cancers, researchers from the Meyer Cancer Center were able to eliminate cancerous cells in cultures and mice. Read more
